InsiderTrades

Form 4 for FDS FactSet

Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-10 · accession 0001013237-21-000174 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-12 2021-11-10 FDS Reeve Jonathan EVP, Head of CTS M - OptEx $316.71 +735 845.84 +663% +$232.8K
D 2021-11-12 2021-11-10 FDS Reeve Jonathan EVP, Head of CTS S - Sale+OE $451.24 -735 110.84 -87% -$331.7K
D 2021-11-12 2021-11-10 FDS Reeve Jonathan EVP, Head of CTS M - OptEx $0.00 -735 2,941 -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-10 M A 735 $316.71 845.84 D — —
2 Common Common Stock 2021-11-10 S D 735 $451.24 110.84 D — — (F1) This transaction was executed in multiple trades with sales prices ranging from $450.98 to $451.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3 Derivative Non-Qualified Stock Option (right to buy) 2021-11-10 M D 735 $0.00 2,941 D $316.71 · — to 2030-11-09 735 Common Stock (F2) Options were granted on November 9, 2020 and vest 20% per year over five years upon the anniversary of the date of grant.